Skip to main content
. 2016 Jun 22;5(6):509–516. doi: 10.1002/cpdd.272

Figure 1.

Figure 1

LS mean of treatment difference from placebo for QTcF change from baseline (± 90%CI). ΔΔQTcF, change from baseline in QTcF between each active treatment relative to placebo; CAB, cabotegravir; LS, least squares; Moxi, moxifloxacin; PBO, placebo.